Levetiracetam Related Compound A
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

102767-31-7Levetiracetam Related Compound A

● Auf Lager

Katalog-Nr.::VL1280012
CAS-Nr.::102767-31-7
Summenformel::C₈H₁₅ClN₂O₂
Molare Masse::206.67

Zusätzliche Informationen zu CAS 102767-31-7

Parent drug

Levetiracetam

IUPAC-Name

(S)-N-(1-Amino-1-oxobutan-2-yl)-4-chlorobutanamide.

Pharmakopöe-Synonyme

N/A

Other Synonyms

(2S)-2-(4-chlorobutanoylamino)butanamide

Smile

O=C(N[C@@H](CC)C(N)=O)CCCCl

InChI

InChI=1S/C8H15ClN2O2/c1-2-6(8(10)13)11-7(12)4-3-5-9/h6H,2-5H2,1H3,(H2,10,13)(H,11,12)/t6-/m0/s1

Beschreibung

Levetiracetam Related Compound A is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Levetiracetam. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications. Levetiracetam is used with other medications to treat seizures. It belongs to a class of drugs known as anticonvulsants.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url